Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Cohen, J A; Cutter, G R; Fischer, J S; Goodman, A D; Heidenreich, F R; Jak, A J; Kniker, J E; Kooijmans, M F; Lull, J M; Sandrock, A W; Simon, J H; Simonian, N A; Whitaker, J N

Cohen, J A; Cutter, G R; Fischer, J S; Goodman, A D; Heidenreich, F R; Jak, A J; Kniker, J E; Kooijmans, M F; Lull, J M; Sandrock, A W; Simon, J H; Simonian, N A; Whitaker, J N.

Affiliation

Cohen JA; The Mellen Center-U10, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. cohenj@ccf.org

Arch Neurol ; 58(6): 961-7, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11405811

Subject(s)

Health Personnel/education; Multiple Sclerosis/diagnosis; Neurologic Examination/methods; Outcome Assessment, Health Care; Sickness Impact Profile; Adult; Female; Humans; Male; Middle Aged; Multiple Sclerosis/classification; Quality of Life; Reproducibility of Results; Statistics, Nonparametric

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Outcome Assessment, Health Care / Health Personnel / Sickness Impact Profile / Multiple Sclerosis / Neurologic Examination Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Arch Neurol Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links